Cerebrovascular Disease, Cognitive Impairment and Dementia. John O'Brien, David Ames, Lars Gustafson, Marshal Folstein, and Edmond Chiu (Eds.). 2004. London: Martin Dunitz, 406 pp., $79.95 (HB).Cerebrovascular Disease, Cognitive Impairment and Dementiais the second edition ofCerebrovascular Disease and Dementia(2000). The new edition is over 160 pages longer than the earlier version, with several new chapters devoted to the pathophysiology of cerebrovascular disease [including provocative chapters on neurotransmitter changes in vascular dementia (VaD), the contributions of homocysteine and low vitamin B to VaD, and a good overview of hereditary forms of VaD], vascular mild cognitive impairment, noncognitive symptoms, and an expanded discussion of prevention and treatment. It is written for both clinical and scientific audiences. As in the first edition, there is a laudable comparative emphasis, with epidemiologic studies of vascular dementia in Europe, North America, Japan, and China. Indeed, the editors hail from the U.K, Australia, Sweden, and the U.S, and this affords the volume a useful global perspective. With five editors and 22 additional contributors, however, this book suffers a bit from the “too many cooks” syndrome. There is a good bit of redundancy. After the fifth or sixth description of classification criteria for vascular dementia, the reader begins to feel on the receiving end of some repetitive rehearsal therapy for her own dementia.
Medical Malpractice and Compensation in Global Perspective: How Does the U.S. Do It?
